1 results match your criteria: "University of Southern California School of Medicine and Women's and Children's Hospital[Affiliation]"
Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant disease. Trovafloxacin Surgical Group.
Am J Surg
December 1998
Department of Obstetrics and Gynecology, University of Southern California School of Medicine and Women's and Children's Hospital, Los Angeles 90033, USA.
Background: Trovafloxacin is a new fourth-generation fluoroquinolone whose pharmacokinetics and in vitro activity suggest that it is well suited for antibiotic prophylaxis in elective hysterectomy.
Methods: In a randomized, double-blind, multicenter study, parallel groups of women 18 years of age or older received either 200 mg trovafloxacin by mouth and intravenous (i.v.